| Application of quality by design to the development of analytical separation methods S Orlandini, S Pinzauti, S Furlanetto Analytical and bioanalytical chemistry 405, 443-450, 2013 | 262 | 2013 |
| Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients P Mura, A Manderioli, G Bramanti, S Furlanetto, S Pinzauti International Journal of Pharmaceutics 119 (1), 71-79, 1995 | 180 | 1995 |
| Simultaneous liquid chromatographic analysis of catecholamines and 4-hydroxy-3-methoxyphenylethylene glycol in human plasma: comparison of amperometric and coulometric detection C Sabbioni, MA Saracino, R Mandrioli, S Pinzauti, S Furlanetto, G Gerra, ... Journal of Chromatography A 1032 (1-2), 65-71, 2004 | 144 | 2004 |
| Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex N Mennini, S Furlanetto, M Cirri, P Mura European journal of Pharmaceutics and Biopharmaceutics 80 (1), 67-75, 2012 | 139 | 2012 |
| LC coupled to ion-trap MS for the rapid screening and detection of polyphenol antioxidants from Helichrysum stoechas M Carini, G Aldini, S Furlanetto, R Stefani, RM Facino Journal of pharmaceutical and biomedical analysis 24 (3), 517-526, 2001 | 139 | 2001 |
| Influence of the preparation method on the physicochemical properties of ketoprofen–cyclodextrin binary systems P Mura, MT Faucci, PL Parrini, S Furlanetto, S Pinzauti International journal of pharmaceutics 179 (1), 117-128, 1999 | 135 | 1999 |
| Validation of a RP-LC method for the simultaneous determination of isoniazid, pyrazinamide and rifampicin in a pharmaceutical formulation E Calleri, E De Lorenzi, S Furlanetto, G Massolini, G Caccialanza Journal of pharmaceutical and biomedical analysis 29 (6), 1089-1096, 2002 | 125 | 2002 |
| Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives L Filippi, G Cavallaro, P Bagnoli, M Dal Monte, P Fiorini, G Donzelli, ... The Journal of pediatrics 163 (6), 1570-1577. e6, 2013 | 116 | 2013 |
| Characterization of physicochemical properties of naproxen systems with amorphous β-cyclodextrin-epichlorohydrin polymers P Mura, MT Faucci, F Maestrelli, S Furlanetto, S Pinzauti Journal of pharmaceutical and biomedical analysis 29 (6), 1015-1024, 2002 | 111 | 2002 |
| Multivariate optimization of capillary electrophoresis methods: a critical review S Orlandini, R Gotti, S Furlanetto Journal of Pharmaceutical and Biomedical Analysis 87, 290-307, 2014 | 110 | 2014 |
| Analysis of catechins in Theobroma cacao beans by cyclodextrin-modified micellar electrokinetic chromatography R Gotti, S Furlanetto, S Pinzauti, V Cavrini Journal of Chromatography A 1112 (1-2), 345-352, 2006 | 104 | 2006 |
| Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design C Sánchez-Lafuente, S Furlanetto, M Fernández-Arévalo, ... International journal of pharmaceutics 237 (1-2), 107-118, 2002 | 104 | 2002 |
| Identification and determination of mainstream and sidestream smoke components in different brands and types of cigarettes by means of solid-phase microextraction–gas … G Pieraccini, S Furlanetto, S Orlandini, G Bartolucci, I Giannini, S Pinzauti, ... Journal of chromatography A 1180 (1-2), 138-150, 2008 | 99 | 2008 |
| Study of formulation variables influencing the drug release rate from matrix tablets by experimental design S Furlanetto, M Cirri, F Maestrelli, G Corti, P Mura European journal of pharmaceutics and biopharmaceutics 62 (1), 77-84, 2006 | 96 | 2006 |
| Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization M Cirri, F Maestrelli, G Corti, S Furlanetto, P Mura Journal of pharmaceutical and biomedical analysis 42 (1), 126-131, 2006 | 90 | 2006 |
| Development and characterization of functionalized niosomes for brain targeting of dynorphin-B M Bragagni, N Mennini, S Furlanetto, S Orlandini, C Ghelardini, P Mura European Journal of Pharmaceutics and Biopharmaceutics 87 (1), 73-79, 2014 | 86 | 2014 |
| Experimental design in the development of voltammetric method for the assay of omeprazole S Pinzauti, P Gratteri, S Furlanetto, P Mura, E Dreassi, R Phan-Tan-Luu Journal of pharmaceutical and biomedical analysis 14 (8-10), 881-889, 1996 | 83 | 1996 |
| Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491 L Filippi, G Cavallaro, P Fiorini, M Daniotti, V Benedetti, G Cristofori, ... BMC pediatrics 10, 1-11, 2010 | 82 | 2010 |
| Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: a safety study L Filippi, C Poggi, G la Marca, S Furlanetto, P Fiorini, G Cavallaro, ... The Journal of pediatrics 157 (3), 361-366, 2010 | 79 | 2010 |
| Determination of aminorex in human urine samples by GC–MS after use of levamisole E Bertol, F Mari, MG Di Milia, L Politi, S Furlanetto, SB Karch Journal of pharmaceutical and biomedical analysis 55 (5), 1186-1189, 2011 | 78 | 2011 |
